Myrra - Company finances
|
EUR
|
2021
From: 2021-01-22
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|
|
Financial data
|
|||||
| Sales revenue | 12,312 | 3,502 | 664 | 6,163 | 5,931 |
| Profit before tax | 1,107 | -813 | -292 | -150 | 192 |
| Net profit | 1,107 | -813 | -292 | -150 | 157 |
| Equity | 1,107 | 294 | 587 | -47 | 110 |
| Liabilities | - | 0 | 0 | 483 | 35 |
| Non-current assets | 0 | 0 | 0 | 0 | 0 |
| Current assets | 1,107 | 294 | 587 | 436 | 145 |
| Total assets | 1,107 | 294 | 587 | 436 | 145 |
|
Financial indicators
|
|||||
| Revenue change y/y | - | -71.6% | -81.0% | +828.2% | -3.8% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 100.0% | -276.5% | -49.7% | -34.4% | 108.3% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 100.0% | -276.5% | -49.7% | - | 142.7% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 9.0% | -23.2% | -44.0% | -2.4% | 2.6% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 9.0% | -23.2% | -44.0% | -2.4% | 3.2% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | - | - | - | 0.3 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | - | - | - | - |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Myrra - Social security debts
The amount of overdue SODRA debt for the company Myrra as of the last working day is: 48 €
| From | To | Debt, € |
|---|---|---|
| 2026-09-05 | 2026-09-14 | 48.18 |
| 2026-09-01 | 2026-09-02 | 120.63 |
| 2026-08-26 | 2026-08-31 | 40.15 |
| 2026-08-23 | 2026-08-23 | 40.15 |
| 2026-08-19 | 2026-08-19 | 40.15 |
| 2026-08-16 | 2026-08-17 | 40.15 |
| 2026-08-04 | 2026-08-14 | 40.15 |
| 2026-08-01 | 2026-08-03 | 112.60 |
| 2026-07-04 | 2026-07-31 | 32.12 |
| 2026-07-01 | 2026-07-03 | 104.57 |
| 2026-06-04 | 2026-06-30 | 24.09 |
| 2026-06-02 | 2026-06-03 | 96.54 |
| 2026-05-04 | 2026-06-01 | 16.06 |
| 2026-05-03 | 2026-05-03 | 88.51 |
| 2026-04-04 | 2026-04-30 | 8.03 |
| 2026-04-01 | 2026-04-03 | 80.48 |
| 2026-03-04 | 2026-03-31 | 16.06 |
| 2026-03-03 | 2026-03-03 | 88.51 |
| 2026-02-04 | 2026-03-02 | 8.03 |
| 2026-02-03 | 2026-02-03 | 80.48 |
| 2025-12-02 | 2026-01-31 | 72.45 |
| 2025-09-07 | 2025-11-30 | 72.45 |
| 2025-09-02 | 2025-09-06 | 144.90 |
| 2025-08-04 | 2025-09-01 | 72.45 |
| 2025-08-01 | 2025-08-03 | 144.90 |
| 2025-07-04 | 2025-07-31 | 72.45 |
| 2025-07-01 | 2025-07-03 | 144.90 |
| 2025-06-03 | 2025-06-30 | 72.45 |
| 2025-04-01 | 2025-04-30 | 72.45 |
| 2025-03-04 | 2025-03-31 | 209.40 |
| 2025-03-03 | 2025-03-03 | 136.95 |
| 2025-03-01 | 2025-03-02 | 209.40 |
| 2025-02-11 | 2025-02-28 | 136.95 |
| 2025-02-10 | 2025-02-10 | 64.50 |
| 2025-02-01 | 2025-02-09 | 136.95 |
| 2025-01-02 | 2025-01-31 | 64.50 |
| 2024-12-03 | 2024-12-31 | 64.50 |
| 2024-06-03 | 2024-06-30 | 64.50 |
| 2024-01-03 | 2024-01-31 | 234.52 |
| 2023-12-01 | 2024-01-02 | 175.89 |
| 2023-11-03 | 2023-11-30 | 117.26 |
| 2023-10-03 | 2023-11-02 | 58.63 |
| 2023-09-01 | 2023-09-30 | 117.26 |
| 2023-08-01 | 2023-08-31 | 58.63 |
| 2023-07-17 | 2023-07-31 | 82.07 |
| 2023-07-14 | 2023-07-16 | 85.18 |
| 2023-07-03 | 2023-07-13 | 234.52 |
| 2023-06-01 | 2023-07-02 | 175.89 |
| 2023-05-04 | 2023-05-31 | 117.26 |
| 2023-05-02 | 2023-05-03 | 58.63 |
| 2023-04-11 | 2023-04-30 | 58.63 |
| 2023-04-03 | 2023-04-10 | 153.44 |
| 2023-03-13 | 2023-04-02 | 94.81 |
| 2023-03-01 | 2023-03-12 | 168.21 |
| 2023-02-01 | 2023-02-28 | 109.58 |
| 2023-01-03 | 2023-01-31 | 50.95 |
| 2022-12-01 | 2022-12-31 | 152.85 |
| 2022-11-03 | 2022-11-30 | 101.90 |
| 2022-10-03 | 2022-11-02 | 50.95 |
| 2022-09-01 | 2022-09-30 | 203.80 |
| 2022-08-02 | 2022-08-31 | 152.85 |
| 2022-07-01 | 2022-08-01 | 101.90 |
| 2022-05-03 | 2022-06-30 | 50.95 |
| 2022-02-01 | 2022-04-30 | 50.95 |
| 2022-01-03 | 2022-01-31 | 44.81 |
| 2021-11-04 | 2021-12-31 | 44.81 |
| 2021-08-13 | 2021-10-31 | 44.81 |
Myrra - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
305688062 Myrra, MB is a small partnership engaged in retail sale of pharmaceutical products. In 2025, revenue reached EUR 5.9K, down 3.8% year on year from EUR 6.2K in 2024, but still far above the EUR 664 recorded in 2023. The company returned to profitability in 2025 with net profit of EUR 157 and a 2.6% profit margin, after losses of EUR 292 in 2023 and EUR 150 in 2024. Over the three-year period, revenue expanded sharply from a very low base, while profitability improved from negative results to a modest positive outcome. At the end of 2025, total assets were EUR 145, equity EUR 110 and liabilities EUR 35, indicating a lightly leveraged balance sheet with a debt-to-equity ratio of 0.32 and an equity ratio of 75.9%. Returns on equity and assets were elevated, reflecting the very small equity and asset base, and asset turnover was also high.